Synchron Gains on Buying into Acquandas
Neurotech startup Synchron (NASDAQ:SNCR) is ramping up production of its flagship brain-computer interface ...
Synchronoss (SNCR) Reports Q1 Loss, Misses Revenue Estimates
Synchronoss (SNCR) delivered earnings and revenue surprises of -300% and 0.47%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Synchronoss (SNCR) to Report Q3 Earnings: What's in Store?
Synchronoss' (SNCR) third-quarter results are expected to reflect an expanding partner base and customer base driven by strong demand for its cloud-based solutions.